Literature DB >> 24114005

Cost-effectiveness of (99m)Tc-MIBI in the evaluation of thyroid nodules for malignancy: a new lease of life for an old radiopharmaceutical?

Frederik A Verburg1, Florian F Behrendt, Felix M Mottaghy, Alexander Heinzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24114005     DOI： 10.1007/s00259-013-2583-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

1.  A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.

Authors:  Koray Demirel; Ozlem Kapucu; Cem Yücel; Hakan Ozdemir; Göksun Ayvaz; Ferit Taneri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-01       Impact factor: 9.236

2.  Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective.

Authors:  P Mernagh; S Campbell; M Dietlein; M Luster; E Mazzaferri; A R Weston
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

3.  Myocardial kinetics of 99Tcm hexakis-(2-methoxy-isobutyl-isonitrile) (HMIBI) in patients with coronary heart disease: a comparative study versus 201Tl with SPECT.

Authors:  H Stirner; U Buell; E Kleinhans; R Bares; W Grosse
Journal:  Nucl Med Commun       Date:  1988-01       Impact factor: 1.690

4.  The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules.

Authors:  E Mezosi; L Bajnok; F Gyory; J Varga; I Sztojka; J Szabo; L Galuska; A Leovey; G Kakuk; E Nagy
Journal:  Eur J Nucl Med       Date:  1999-08

5.  Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area.

Authors:  E Kresnik; H J Gallowitsch; P Mikosch; I Gomez; P Lind
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

6.  (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.

Authors:  Luca Giovanella; Sergio Suriano; Marco Maffioli; Luca Ceriani; Giuseppe Spriano
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

7.  Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule.

Authors:  Luis Mauricio Hurtado-López; Sara Arellano-Montaño; Evelyn Migdalia Torres-Acosta; Felipe Rafael Zaldivar-Ramirez; Reyna Margarita Duarte-Torres; Patricia Alonso-De-Ruiz; Iván Martínez-Duncker; Carlos Martínez-Duncker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-06       Impact factor: 9.236

8.  Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile.

Authors:  I Földes; A Lévay; G Stotz
Journal:  Eur J Nucl Med       Date:  1993-04

9.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Anita Wale; Kenneth A Miles; Barnaby Young; Charles Zammit; Anthony Williams; John Quin; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

10.  Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi.

Authors:  F X Sundram; P Mack
Journal:  Nucl Med Commun       Date:  1995-08       Impact factor: 1.690
View more
  3 in total

1.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules: reply to comments by Riazi et al.

Authors:  Anita Wale; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03       Impact factor: 9.236

2.  Thyroid nodules with indeterminate cytology: molecular imaging with ⁹⁹mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma gene expression classifier.

Authors:  Alexander Heinzel; Dirk Müller; Florian F Behrendt; Luca Giovanella; Felix M Mottaghy; Frederik A Verburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-05       Impact factor: 9.236

3.  Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.

Authors:  Sait Sager; Betul Vatankulu; Ezgi Erdogan; Sanem Mut; Serkan Teksoz; Tulin Ozturk; Kerim Sonmezoglu; Bedii Kanmaz
Journal:  Endocrine       Date:  2015-03-21       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.